3Eden JA, Place J, Carter GD, et al. The effect of clomiphenecitrate on follicular phase increase in endometrial thickness anduterine volume[J]. Obstet Gynecol, 1989,73(2): 187-190.
4Chwalisz K, Larsen L, Mattia-Goldberg C, et al. A randomized,controlled trial of asoprisnil, a novel selective progesteronereceptor modulator, in women with uterine leiomyomata[J].Fertil Steril,2007,87(6): 1399-1412.
5Brown J, Pan A, Hart RJ. Gonadotropin-releasing hormoneanalogues for pain associated with endometriosis[J]. CochraneDatabase Syst Rev,2010,12: CD008475.
6Donnez J, Nisolle M, Gillerot S, et al. Ovarian endometrialcysts: the role of gonadotropin-releasing hormone agonist and/ordrainage[J]. Fertil Steril,1994,62( 1): 63-66.
7Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinicaltrial of a levonorgestrel-releasing intrauterine system and adepot GnRH analogue for the treatment of chronic pelvic painin women with endometriosis[J]. Hum Reprod, 2005, 20 (7):1993-1998.
8Cheng MH,Yu BK, Chang SP, et al. A randomized, parallel,comparative study of the efficacy and safety of nafarelin versusdanazol in the treatment of endometriosis in Taiwan[J]. J ChinMed Assoc,2005,68(7): 307-314.
9Strowitzki T, Marr J, Gerlinger C,et al. Detailed analysis of arandomized, multicenter, comparative trial of dienogest versusleuprolide acetate in endometriosis[J]. Int J Gynaecol Obstet,2012,117(3):228-233.
10Barbieri RL. Hormone treatment of endometriosis: the estrogenthreshold hypothesis[J]. Am J Obstet Gynecol, 1992,166(2):740-745.
